A £150,000 Grant for Business Investment (GBI) from the regional development agency Advantage West Midlands has been enabling Sterling Pharmaceuticals Ltd, a Birmingham-UK based pharmaceutical manufacturing company, to win new contracts and develop new services.
The company, which manufactures oral liquid products both as specials and licensed medicines, is commercialising them to wholesalers, distributors, NHS trusts and community pharmacies.
According to Dr Qamar Nawaz, CEO at Sterling Pharmaceuticals, the grant has allowed the company to invest in plant to develop and test its products and services.
In particular, it has enabled Sterling to target its initial specials medicines market successfully, win almost £350,000 worth of contracts and create 10 new jobs.
Sterling is now exploring the opportunity to provide contract manufacturing services for 3rd party clients for the manufacture of licensed products.
Once further contracts have been secured, the company hopes to be offering more jobs.
FinSMEs
20/01/2010